5-fluorouracil,oxaliplatin,Irinotecan
Not Tagged
['pancreatic', 'nordic']
 presenting #norpact1 at #asco23 : no survival benefit of neoadjuvant folforinox in resectable pancreatic cancer in nordic multicenter population based trial, in itt and per protocol population! 
Father of three. Surgeon, researcher at the Intervention Center and the HPB Surgery department, Oslo University Hospital. Opinions are my own.